“…BALF and plasma mNGS tests were performed in our clinical laboratory to detect both DNA and RNA pathogens. Our recent studies provide a comprehensive description of the analytical and clinical validation of tests, as well as the experimental procedures (eg, sample processing, nucleic acid extraction, library construction, high-throughput sequencing, and bioinformatics analysis), reagents, controls, sequencers, software, and algorithms involved in each step [ 2 , 13 , 14 , 18 , 19 ]. The detected pathogens and the number of sequencing reads (stringent mapped read number [SMRN], referring to the number of reads per pathogen at the sequencing depth of 20 million reads) are sent to the clinical treating team from the clinical laboratory [ 2 ].…”